Executive Profile*

Klaus Sturany

Member of Supervisory Board,RWE Generation SE
AgeTotal Calculated CompensationThis person is connected to 70 board members in 6 different organizations across 15 different industries.

See Board Relationships
70€249,000

Background*

Dr. Klaus Sturany serves as the Chief Financial Officer of RWE AG. Dr. Sturany serves as Member of the Management Board of HOCHTIEF Aktiengesellschaft. He serves as a Member of Management Board of RWE Dea Aktiengesellschaft, RWE Power Aktiengesellschaft, RWE Solutions Aktiengesellschaft, Innogy Holdings plc, RWE Trading GmbH and Thames Water Plc. He served as a Member of the Management Board of Essen Commerzbank Aktiengesellschaft, Hannover Rückversicherungs-Aktien-gesellschaft ...

Read Full Background

Corporate Headquarters*

Guiollettestrasse 44-48
Frankfurt am Main, Hessen 60325

Germany

Phone: 49 69 97 16 20
Fax: 49 69 71 35 12 04

Board Members Memberships*

Director

Education*

Unknown/Other Education
Universität Innsbruck
PhD
Universität Innsbruck

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€249,000
Total Calculated Compensation€249,000
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John F. Milligan Ph.D.Chief Executive Officer, President and Director
Gilead Sciences Inc.
$1.2M
Mark J. Alles Chief Executive Officer and Director
Celgene Corporation
$871.3K
Andrew Philip Witty Chief Executive Officer and Executive Director
GlaxoSmithKline plc
3.3M GBP
David A. Ricks Chief Executive Officer, President and Director
Eli Lilly and Company
--
Richard A. Gonzalez Chairman of the Board and Chief Executive Officer
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.